Veeva Systems (NYSE:VEEV – Get Free Report) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.740-1.750 for the period, compared to the consensus estimate of 1.620. The company issued revenue guidance of $726.0 million-$729.0 million, compared to the consensus revenue estimate of $725.8 million. Veeva Systems also updated its FY 2026 guidance to 7.320-7.320 EPS.
Wall Street Analysts Forecast Growth
VEEV has been the subject of a number of recent research reports. Evercore ISI raised their price target on shares of Veeva Systems from $220.00 to $245.00 and gave the stock an “in-line” rating in a research report on Friday, December 6th. Barclays raised their target price on shares of Veeva Systems from $260.00 to $275.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Stifel Nicolaus upped their price target on shares of Veeva Systems from $240.00 to $272.00 and gave the company a “buy” rating in a report on Friday, December 6th. Royal Bank of Canada lifted their price objective on Veeva Systems from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Scotiabank upped their target price on Veeva Systems from $240.00 to $245.00 and gave the stock a “sector perform” rating in a research note on Thursday. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and an average target price of $255.28.
Read Our Latest Report on Veeva Systems
Veeva Systems Trading Up 7.5 %
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- What Investors Need to Know to Beat the Market
- 4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
- Insider Trades May Not Tell You What You Think
- These 3 Big Banks Are Set to Gain as Consumers Stash More Cash
- How to Effectively Use the MarketBeat Ratings Screener
- Wall Street Says Chipotle Has 30% Upside—Should You Bite?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.